Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-10-073676
Filing Date
2010-03-31
Accepted
2010-03-31 17:26:33
Documents
7
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-K d10ka.htm 10-K/A 250234
2 EMPLOYMENT AGREEMENT dex1030.htm EX-10.30 59131
3 LIST OF SUBSIDIARIES OF THE REGISTRANT dex211.htm EX-21.1 2970
4 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 8488
5 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 8519
6 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 4015
7 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 4030
  Complete submission text file 0001193125-10-073676.txt   338943
Mailing Address 2711 CENTERVILLE ROAD SUITE 400 WILMINGTON DE 19808
Business Address 2711 CENTERVILLE ROAD SUITE 400 WILMINGTON DE 19808 49 6172 608 2327
Fresenius Kabi Pharmaceuticals Holding, Inc. (Filer) CIK: 0001439449 (see all company filings)

EIN.: 980589183 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-34172 | Film No.: 10720726
SIC: 2834 Pharmaceutical Preparations